Highlights

  • Jatcorp reported FY26 Revenue of $38.9 million, up 23% from FY25.
  • Statutory loss after tax improved to $4.7 million from $6.9 million.
  • Moroka expanded across China and Vietnam through new distribution channels.
  • ANMA Manufacturing capability continued to support proprietary and OEM products.

Jatcorp Limited (ASX:JAT) is an Australian health and wellness consumer goods company focused on developing, manufacturing and Marketing nutritional and dairy-based products. The company operates through proprietary brands including Moroka® and Neurio®, supported by its Melbourne-based ANMA manufacturing facility. During FY26, Jatcorp focused on revenue recovery, expanding distribution channels, strengthening manufacturing capability and developing its product portfolio across Australia, China and selected Southeast Asian markets.

FY26 Revenue Growth Supported by Brand and Channel Expansion

Jatcorp reported revenue from operations of $38.9 million for FY26, representing a 23% increase from $31.6 million in FY25. Gross Profit was $6.1 million, broadly in line with the previous year, while Gross Profit Margin declined to 15.81% from 19.77%.

The company recorded a statutory loss after tax of $4.7 million, compared with a loss of $6.9 million in FY25. EBITDA improved to a loss of $3.4 million from a loss of $5.9 million, while Adjusted EBITDA was a loss of $2.7 million.

Jatcorp continued investing in product development, distribution and manufacturing activities during the year. The company highlighted the need to improve margin quality, Working Capital discipline and operating efficiency as key priorities for FY27.

The company’s operations are centred on nutritional products, dairy-based consumer goods and contract manufacturing activities. Its product portfolio includes formulations incorporating lactoferrin and other natural ingredients across different consumer categories.

Moroka and Neurio Brands Expand Across Asia-Pacific Markets

During FY26, Jatcorp progressed its market expansion strategy through new distribution partnerships and broader channel development.

The company commenced an exclusive distribution Partnership in Vietnam, with Moroka sales increasing month-on-month following market entry. Jatcorp also continued discussions with potential distributors in Malaysia and Indonesia to support expansion across Southeast Asia.

In China, the company expanded Moroka into approximately 150 mother and baby retail stores, increasing its presence beyond traditional E-commerce channels. The partnership with HS Global E-Commerce (HK) Limited continued during FY26, with cumulative Moroka purchases exceeding $19 million across FY25 and FY26.

Jatcorp also participated in the China International Import Expo in Shanghai, using the platform to showcase its brands, manufacturing capabilities and product portfolio. The company reported that industry participants and prospective customers subsequently visited its ANMA Facility in Melbourne.

Product innovation remains a focus, with several new SKUs under development targeting areas including immunity, cognitive health and gut health.

ANMA Manufacturing Platform and FY27 Priorities

Jatcorp continued investing in its ANMA manufacturing facility in Melbourne during FY26. The company upgraded infrastructure, automation and production capability to support both proprietary products and OEM manufacturing activities.

ANMA became BTNature’s exclusive manufacturer in Australia and New Zealand during the period, with orders contributing to manufacturing activity.

To support working capital and development initiatives, Jatcorp completed a non-renounceable entitlement offer during FY26, raising approximately $4.2 million before capital raising costs. The company ended FY26 with approximately $5.6 million in cash and cash equivalents.

Looking ahead, Jatcorp’s FY27 priorities include profitable revenue growth, improving gross margins, managing working capital, expanding selected distribution channels and increasing ANMA utilisation.

The company continues to monitor risks including intellectual property matters relating to the Neurio® Trademark in China, customer and market concentration, funding requirements and operating cash flow. Jatcorp aims to strengthen its market presence through brand development, product innovation and manufacturing expansion.

Key Insights

Jatcorp’s FY26 results reflected revenue recovery, wider market distribution and continued Investment in manufacturing capability. The company is focused on expanding Moroka and Neurio brands, improving operating performance and developing additional health and nutrition products.